Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04253483 | Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer | active not recruiting | Phase 2 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT02276430 | TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects(TACkLE) | active not recruiting | — | 939 | University Medical Center GroningenOTHER |
| 1 |
| Sep 15, 2025 |
| clinicaltrials |
| NCT03889119 | Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | active not recruiting | N/A | 100 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05871008 | Integrated Actionable Aging Assessment for Cancer Patients Pilot | active not recruiting | N/A | 35 | University of Colorado, DenverOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT01655836 | High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | active not recruiting | Phase 1 | 42 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06074510 | PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer(MIRROR) | active not recruiting | Phase 4 | 274 | Lantheus Medical ImagingINDUSTRY | 1 | Sep 11, 2025 | clinicaltrials |
| NCT01990521 | Prostate Screening Study Using MRI in BRCA Carriers | active not recruiting | N/A | 60 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.(PASCA) | active not recruiting | N/A | 500 | Centre Leon BerardOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT03317990 | Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.(NeuroSAFEPROOF) | active not recruiting | N/A | 407 | University College, LondonOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT05336786 | Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) | active not recruiting | Phase 3 | 70 | Thomas Jefferson UniversityOTHER | 2 | Sep 4, 2025 | clinicaltrials |
| NCT07155759 | Long-term Outcomes of Prostate Cancer Screening(STHLM3MRI_3) | active not recruiting | N/A | 7,500 | Karolinska InstitutetOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT06703437 | Long Acting Neuraxial Peri-prostatic Block in Cancer | active not recruiting | Phase 1 | 12 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT03385655 | Prostate Cancer Biomarker Enrichment and Treatment Selection | active not recruiting | Phase 2 | 200 | Canadian Cancer Trials GroupNETWORK | 1 | Aug 21, 2025 | clinicaltrials |
| NCT04319783 | Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA(DECREASE) | active not recruiting | Phase 2 | 65 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Aug 21, 2025 | clinicaltrials |
| NCT06824259 | The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer | active not recruiting | N/A | 400 | Peking University First HospitalOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT04015622 | PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA(PROTRACT) | active not recruiting | Phase 2 | 100 | British Columbia Cancer AgencyOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT05645237 | HRQOL in Prostate Cancer Patients Treated With Radiotherapy(PRORAD) | active not recruiting | — | 600 | Erasmus Medical CenterOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT01990196 | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | active not recruiting | Phase 2 | 45 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT02766543 | Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer(TACT) | active not recruiting | N/A | 150 | Profound Medical Inc.OTHER | 5 | Aug 17, 2025 | clinicaltrials |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 | 914 | ExelixisINDUSTRY | 9 | Aug 17, 2025 | clinicaltrials |
| NCT03630666 | Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients(OLIGOPELVIS2) | active not recruiting | N/A | 256 | Institut Cancerologie de l'OuestOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT05027477 | A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer(CAPTAIN) | active not recruiting | N/A | 201 | Profound Medical Inc.OTHER | 3 | Aug 17, 2025 | clinicaltrials |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | active not recruiting | Phase 1 / Phase 2 | 81 | Cancer Research UKOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT01436968 | Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer(PrTK03) | active not recruiting | Phase 3 | 711 | Candel Therapeutics, Inc.INDUSTRY | 2 | Jul 30, 2025 | clinicaltrials |
| NCT01952223 | A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse(PEACE2) | active not recruiting | Phase 3 | 761 | UNICANCEROTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT02768363 | Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) | active not recruiting | Phase 2 | 187 | Candel Therapeutics, Inc.INDUSTRY | 2 | Jul 30, 2025 | clinicaltrials |
| NCT04181203 | Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy(CARLHA-2) | active not recruiting | Phase 3 | 490 | UNICANCEROTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05269550 | PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)(ARGOS/CLIMBER) | active not recruiting | N/A | 50 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT04404894 | Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | active not recruiting | — | 500 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Jul 14, 2025 | clinicaltrials |
| NCT07048613 | Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups | active not recruiting | — | 120 | Superior UniversityOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02817958 | Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis(MEGACEP) | active not recruiting | Phase 2 | 37 | UNICANCEROTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT05768776 | Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology(MOSES) | active not recruiting | — | 200 | University Hospital, BordeauxOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04105920 | Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies(HYALEREC) | active not recruiting | N/A | 162 | Hospices Civils de LyonOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT01342367 | Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer | active not recruiting | N/A | 74 | University of ChicagoOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | active not recruiting | Phase 3 | 11,000 | University College, LondonOTHER | 2 | Jun 10, 2025 | clinicaltrials |
| NCT01550237 | Curative Image Guided Radiotherapy for Prostate Cancer(RIC) | active not recruiting | N/A | 260 | St. Olavs HospitalOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT03564275 | Proton Boost in Prostate Cancer | active not recruiting | N/A | 10 | University of CincinnatiOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT01783145 | Shared Care Follow-up After Chemotherapy for Testicular Cancer(SCFU-TC) | active not recruiting | — | 163 | University Medical Center GroningenOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT02572934 | Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)(STANDBY) | active not recruiting | — | 281 | University Medical Center GroningenOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT03392181 | PET/MRI for the Staging of Newly Diagnosed Prostate Cancer | active not recruiting | Early Phase 1 | 48 | Northwestern UniversityOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT06985004 | Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire | active not recruiting | — | 288 | Pomeranian Medical University SzczecinOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06383052 | A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC | active not recruiting | Phase 1 / Phase 2 | 30 | Norroy Bioscience Co., LTDINDUSTRY | 1 | May 21, 2025 | clinicaltrials |
| NCT05592639 | VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer(VELRAD) | active not recruiting | N/A | 50 | University College, LondonOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04848909 | Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy(PLUTO-MPC) | active not recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT03874884 | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer(LuPARP) | active not recruiting | Phase 1 | 70 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT04484701 | [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | active not recruiting | — | 1,574 | British Columbia Cancer AgencyOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT03703778 | Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)(READT) | active not recruiting | — | 300 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT04253262 | A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer | active not recruiting | Phase 1 / Phase 2 | 13 | Brown UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT03998657 | Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions | active not recruiting | N/A | 14 | InSightecINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 17, 2025source: clinicaltrials